1
|
Ngo LC, Nahon-Estève S, Maschi C, Martel A, Lassalle S, Tieulie N, Baillif S. Clinical features, diagnosis, treatment, and course of ocular sarcoidosis with or without uveitis: A retrospective, comparative study. J Fr Ophtalmol 2024; 47:104153. [PMID: 38696861 DOI: 10.1016/j.jfo.2024.104153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 10/26/2023] [Accepted: 12/12/2023] [Indexed: 05/04/2024]
Abstract
OBJECTIVE To evaluate and compare characteristics, diagnosis, treatment, visual prognosis, and course between ocular sarcoidosis with or without uveitis in a population in Southern France. METHODS We retrospectively analyzed data from patients with ocular sarcoidosis in a tertiary eye care center in Nice from January 2003 to December 2021. The inclusion criterion was biopsy-proven ocular sarcoidosis according to IWOS criteria as the first clinical manifestation of sarcoidosis. RESULTS A total of 25 patients were included. Twenty patients had uveitis (70% panuveitis, 20% intermediate uveitis, and 10% anterior uveitis) and five patients had non-uveitic ocular sarcoidosis (one patient with dacryoadenitis, one patient with orbital granuloma, two patients with palpebral granuloma, and one patient with episcleritis). Only the cases with uveitis had bilateral involvement (85% of cases). There was no significant difference in ethnicity, biopsy diagnosis, systemic manifestations, or treatment between the two groups. Final visual outcomes remained good for both groups, with 96% of patients with BCVA>20/50, with no significant difference. Patients with non-uveitic sarcoidosis experienced less recurrence on treatment (P=0.042) and more remission (P=0.038) than patients with uveitis. Eighty percent of patients with uveitis had at least three suggestive clinical intraocular signs meeting IWOS criteria. CONCLUSION In this population in Southern France, uveitis was the most common presentation of ocular sarcoidosis. The type of ocular sarcoidosis does not appear to be correlated with the type of systemic manifestations, use of systemic therapy, or visual prognosis, but patients with non-uveitic ocular sarcoidosis appear to have a better course with fewer recurrences on treatment and more remission than patients with uveitic ocular sarcoidosis.
Collapse
Affiliation(s)
- L C Ngo
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| | - S Nahon-Estève
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France; Laboratoire d'anatomopathologie, FHU OncoAge, BB-0033-00025, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France.
| | - C Maschi
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| | - A Martel
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France; Laboratoire d'anatomopathologie, FHU OncoAge, BB-0033-00025, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| | - S Lassalle
- Laboratoire d'anatomopathologie, FHU OncoAge, BB-0033-00025, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| | - N Tieulie
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| | - S Baillif
- Service d'ophtalmologie, université Côte-d'Azur, centre hospitalier universitaire de Nice, Nice, France
| |
Collapse
|
2
|
Abstract
Interstitial nephritis is responsible for about 12 % of end-stage renal disease in Germany. It comprises an etiologically heterogenous group of inflammatory renal disorders which primarily affect the renal interstitium and tubuli. Drugs, predominantly antibiotics, nonsteroidal anti-inflammatory drugs and proton pump inhibitors are causative in the majority of cases. Rheumatic diseases frequently affect the kidneys, either the glomeruli or the interstitial tissues. Inflammatory interstitial processes can be accompanied by complex functional tubular disorders. This review gives an overview about clinical and laboratory findings of interstitial nephritis in the context of rheumatic diseases. Sarcoidosis, tubulointerstitial nephritis and uveitis (TINU) syndrome, primary Sjogren's syndrome, and IgG4-related disease often show an interstitial nephritis when the kidneys are affected. Other diseases, such as systemic lupus erythematosus, systemic sclerosis, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, and granulomatosis with polyangiitis are more rarely associated with predominant interstitial nephritis. Glucocorticoids are the mainstay of therapy for most cases; in refractory cases or when side effects occur, second-line immunosuppressants such as mycophenolate mofetil, azathioprine and others, rarely biologics, can be used.
Collapse
Affiliation(s)
- P Korsten
- Klinik für Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland
| | | |
Collapse
|